Research Article
Human Papilloma Virus Infection in Patients with Male Accessory Gland Infection: Usefulness of the Ultrasound Evaluation
Table 3
Ultrasound features in the three groups of patients with male accessory gland infection/inflammation (MAGI) enrolled in this study.
| Parameters | MAGI HPV-positive | MAGI Chlamydia-positive | Inflammatory MAGI |
| Ultrasound (US) features | Total number of US criteria suggestive for MAGI | 18.0 ± 2.0 | 12.0 ± 4.0 | 10.0 ± 3.0 | Total number of US criteria in the prostate periurethral zone | 5.0 ± 1.0 | 2.0 ± 1.0 | 2.0 ± 1.0 | Total number of US criteria in the prostate lobar zone | 1.0 ± 1.0 | 4.0 ± 1.0 | 4.0 ± 1.0 |
| Prevalence of the various diagnostic categories of MAGI | Prostatitis (%) | 18.0 ± 6.0 | 27.0 ± 5.0 | 65.0 ± 10.0 | Prostate-vesiculitis (%) | 40.0 ± 10.0 | 45.0 ± 5.0 | 20.0 ± 5.0 | Prostate-vesiculitis-epididymitis (%) |
42.0 ± 4.0 | 28.0 ± 5.0 | 15.0 ± 5.0 |
| Prevalence of monolateral versus bilateral forms of MAGI | Monolateral prostatitis (%) | 10.0 ± 3.0 | 17.0 ± 5.0 | 45.0 ± 5.0 | Monolateral prostate-vesiculitis (%) | 10.0 ± 5.0 | 15.0 ± 5.0 | 15.0 ± 5.0 | Monolateral prostate-vesiculitis-epididymitis (%) | 12.0 ± 5.0 | 10.0 ± 5.0 | 10.0 ± 5.0 | Bilateral prostatitis (%) | 8.0 ± 3.0 | 10.0 ± 5.0 | 20.0 ± 5.0 | Bilateral prostate-vesiculitis (%) | 30.0 ± 5.0 | 30.0 ± 5.0 | 5.0 ± 5.0 | Bilateral prostate-vesiculitis-epididymitis (%) | 30.0 ± 5.0 | 18.0 ± 5.0 | 5.0 ± 5.0 |
| Prevalence of fibrosclerotic versus hypertrophic-congestive variant of MAGI | Fibrosclerotic MAGI (%) | 70.0 ± 10.0 | 48.0 ± 5.0 | 15.0 ± 10.0 | Hypertrophic-congestive MAGI (%) | 30.0 ± 10.0 | 52.0 ± 5.0 | 85.0 ± 10.0 |
|
|
HPV: human papilloma virus. versus patients with MAGI Chlamydia trachomatis-positive; versus patients with inflammatory MAGI.
|